Quest Diagnostics (DGX)

The company’s testing menu spans routine blood work, anatomic pathology, molecular and genetic testing, women’s health, infectious disease, cardiometabolic testing, oncology, and drug monitoring. Quest also provides more specialised esoteric tests that may require advanced technology or expert interpretation. This breadth makes the company a key part of the healthcare system, as laboratory results influence a large share of medical decisions while often representing a relatively small portion of overall care costs.

Beyond its main diagnostics operations, Quest offers services that support clinical trials, employer health programmes, risk assessment, and healthcare information management. It has also built digital tools that allow patients and clinicians to access results, schedule appointments, and manage testing more efficiently. The business benefits from recurring demand for medical testing, demographic trends such as an ageing population, and the increasing use of diagnostics in personalised medicine. At the same time, it operates in a regulated and competitive market where reimbursement rates, payer contracts, hospital partnerships, and testing innovation are important drivers of performance.